CDMO Samsung Biologics Releases Q4 2023 Earnings, Surpasses 1 Trillion KRW To Mark a ‘Decade of Operational Excellence’
Samsung Biologics, one of the world’s largest contract development and manufacturing organizations, announced its earnings for the final quarter of 2023, noting that it surpassed 1 trillion South Korean won…